מדינה: מלטה
שפה: אנגלית
מקור: Medicines Authority
LAMIVUDINE
Aurobindo Pharma (Malta) Limited Vault 14, Level 2, Valletta Waterfront, Floriana FRN 1913, Malta
J05AF05
LAMIVUDINE 300 mg
FILM-COATED TABLET
LAMIVUDINE 300 mg
POM
ANTIVIRALS FOR SYSTEMIC USE
Withdrawn
2013-04-24
Page 1 of 8 PACKAGE LEAFLET: INFORMATION FOR THE USER LAMIVUDINE AUROBINDO 300 MG FILM-COATED TABLETS lamivudine READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects , talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Lamivudine Aurobindo is and what it is used for 2. What you need to know before you take Lamivudine Aurobindo 3. How to take Lamivudine Aurobindo 4. Possible side effects 5. How to store Lamivudine Aurobindo 6. Contents of the pack and other information 1. WHAT LAMIVUDINE AUROBINDO IS AND WHAT IT IS USED FOR LAMIVUDINE AUROBINDO IS USED TO TREAT HIV (HUMAN IMMUNODEFICIENCY VIRUS) INFECTION IN ADULTS AND CHILDREN. The active ingredient in Lamivudine Aurobindo is lamivudine. Lamivudine Aurobindo is a type of medicine known as an anti-retroviral. It belongs to a group of medicines called _nucleoside analogue _ _reverse transcriptase inhibitors (NRTIs)_. Lamivudine Aurobindo does not completely cure HIV infection; it reduces the amount of virus in your body, and keeps it at a low level. It also increases the CD4 cell count in your blood. CD4 cells are a type of white blood cells that are important in helping your body to fight infection. Not everyone responds to treatment with Lamivudine Aurobindo in the same way. Your doctor will m קרא את המסמך השלם
Page 1 of 12 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Lamivudine Aurobindo 300 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 300 mg lamivudine. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet Grey, film-coated, diamond shaped tablets, debossed with ‘Z26’ on one side and plain on other side. The size is 17.5 mm X 8.6 mm. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Lamivudine Aurobindo is indicated as part of antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infected adults and children. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The therapy should be initiated by a physician experienced in the management of HIV infection. Lamivudine Aurobindo may be administered with or without food. To ensure administration of the entire dose, the tablet(s) should ideally be swallowed without crushing. For patients who are unable to swallow tablets, lamivudine is available as an oral solution. Alternatively, the tablets may be crushed and added to a small amount of semi-solid food or liquid, all of which should be consumed immediately (see section 5.2). _ _ _Adults and adolescents over 12 years of age: _the recommended dose of Lamivudine Aurobindo is 300 mg daily. This may be administered as either 150 mg twice daily or 300 mg once daily (see section 4.4). The 300 mg tablet is only suitable for the once a day regimen. Patients changing to the once daily regimen should take 150 mg twice a day and switch to 300 mg once a day the following morning. Where an evening once daily regimen is preferred, 150 mg of Lamivudine Aurobindo should be taken o קרא את המסמך השלם